Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

102.49
-0.3700-0.36%
Post-market: 102.490.00000.00%19:30 EDT
Volume:87.75K
Turnover:8.99M
Market Cap:4.32B
PE:-99.67
High:102.87
Open:102.55
Low:102.15
Close:102.86
52wk High:107.69
52wk Low:85.36
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.24
T/O Rate:0.21%
Dividend:1.38
Dividend Rate:1.34%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.12
PE(LYR):-99.67

Loading ...

Maybe the Snowbirds are Right? One State Dominates This List of Best Places to Retire.

Dow Jones
·
Yesterday

How an HSA Can Help You Save for Retirement

Dow Jones
·
Yesterday

Retension Pharmaceuticals, TRex Bio File for US IPO as Biotech Momentum Continues

Reuters
·
Yesterday

Teva presents new new real-world data on uzedy at Psych Congress

TIPRANKS
·
Yesterday

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Generate Steady Cash

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Eli Lilly reports full FDA approval of Inluriyo combo for certain breast cancers

TIPRANKS
·
Yesterday

US FDA Approves Lilly Inluriyo-Verzenio Combo for ESR1-Mutated Metastatic Breast Cancer

Reuters
·
Yesterday

U.S. FDA Approves Inluriyo (Imlunestrant) in Combination with Verzenio (Abemaciclib) for Adults with Er+, Her2-, Esr1-Mutated Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Yesterday

Eli Lilly - Inluriyo with Verzenio NOW Available in the United States

THOMSON REUTERS
·
Yesterday

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Sep 18

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
Sep 18

Merck Says EU CHMP Backs Keytruda-Padcev Perioperative Use in Resectable Muscle-Invasive Bladder Cancer

Reuters
·
Sep 18

Merck & Co - Final Ec Decision Expected by Q4 2026

THOMSON REUTERS
·
Sep 18

Merck Receives Positive EU Chmp Opinion for Keytruda® (Pembrolizumab) Plus Padcev® (Enfortumab Vedotin-Ejfv) as Perioperative Treatment for Adults with Resectable Muscle-Invasive Bladder Cancer (Mibc)

THOMSON REUTERS
·
Sep 18

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living with Hiv

THOMSON REUTERS
·
Sep 18

All 50 States Sign up for Trump's Medicaid Most-Favored-Nation Plan

Reuters
·
Sep 18

Turk Ilac ve Serum Sanayi Wins State Health Procurement Tender

TIPRANKS
·
Sep 18

When Weight Loss Isn't the Goal of Taking a GLP-1

Dow Jones
·
Sep 18